$1.23
0.46%
Nasdaq, Mon, Aug 25 2025

China Jo-Jo Drugstores, Inc. Stock price

$1.23
-0.07 5.05% 1M
-0.23 15.46% 6M
-0.54 30.27% YTD
-0.45 26.53% 1Y
-55.77 97.83% 3Y
-277.17 99.56% 5Y
-413.97 99.70% 10Y
-0.27 17.71% 20Y
Nasdaq, Closing price Mon, Aug 25 2025
-0.01 0.46%

Key metrics

Basic
Market capitalization
$7.2m
Enterprise Value
$4.8m
Net debt
positive
Cash
$12.8m
Shares outstanding
5.9m
Valuation (TTM | estimate)
P/E
0.7 | -
P/S
0.1 | -
EV/Sales
0.0 | -
EV/FCF
7.7
P/B
0.2
Financial Health
Equity Ratio
46.0%
Return on Equity
34.4%
ROCE
-3.4%
ROIC
-5.7%
Debt/Equity
0.4
Financials (TTM | estimate)
Revenue
$120.0m | -
EBITDA
$5.0m | -
EBIT
$-1.0m | -
Net Income
$10.2m | -
Free Cash Flow
$630.0k
Growth (TTM | estimate)
Revenue
-3.2% | -
EBITDA
-16.7% | -
EBIT
-273.7% | -
Net Income
340.9% | -
Free Cash Flow
115.4%
Margin (TTM | estimate)
Gross
3.2%
EBITDA
4.2% | -
EBIT
-0.9%
Net
8.5% | -
Free Cash Flow
0.5%
More
EPS
$1.8
FCF per Share
$0.1
Short interest
0.2%
Employees
-
Rev per Employee
-
Show more

Is China Jo-Jo Drugstores, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Financial data from China Jo-Jo Drugstores, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
120 120
3% 3%
100%
- Direct Costs 116 116
3% 3%
97%
3.84 3.84
21% 21%
3%
- Selling and Administrative Expenses 4.87 4.87
14% 14%
4%
- Research and Development Expense - -
-
-
4.98 4.98
17% 17%
4%
- Depreciation and Amortization 6.02 6.02
12% 12%
5%
EBIT (Operating Income) EBIT -1.04 -1.04
274% 274%
-1%
Net Profit 10 10
341% 341%
8%

In millions USD.

Don't miss a Thing! We will send you all news about China Jo-Jo Drugstores, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

China Jo-Jo Drugstores, Inc. engages in the distribution and retail of pharmaceutical and other healthcare products. It operates through the following business segments: Retail Drugstores, Online Pharmacy; Drug Wholesale; and Herb Farming. The Retail Drugstores segment sells prescription and over-the-counter medicines, dietary supplements, medical devices, and sundry items to retail customers. The Online Pharmacy segment offers over-the-counter drugs, dietary supplements, medical devices and sundry items to customers through several third-party platforms. The Drug Wholesale segment includes supplying the company's own retail drugstores with prescription. The Herb Farming cultivates selected herbs for sales to other drug vendors. The company was founded by Lei Liu and Li Qi on December 19, 2006 and is headquartered in Hangzhou, China.

Head office United States
CEO Lei Liu
Founded 2003
Website www.jiuzhou360.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today